Implementation of a culturally competent APOL1 genetic testing programme into living donor evaluation: A two-site, non-randomised, pre–post trial design

Introduction While living donor (LD) kidney transplantation is the optimal treatment for patients with kidney failure, LDs assume a higher risk of future kidney failure themselves. LDs of African ancestry have an even greater risk of kidney failure post-donation than White LDs. Because evidence sugg...

Full description

Bibliographic Details

Published in:	BMJ Open
Main Authors:	Matthew Cooper, Justin D Smith, Clyde W Yancy, Elisa J Gordon, Akansha Agrawal, Catherine Wicklund, Debra Duquette, John Friedewald, Luke V Rasmussen, Jessica Gacki-Smith, S. Darius Tandon, Lutfiyya N Muhammad, Siyuan Dong, Alexander Gilbert, Aneesha Shetty
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-05-01
Online Access:	https://bmjopen.bmj.com/content/13/5/e067657.full